JTC PLC Reports Strong 2025 Full-Year Results with 25% Revenue Growth Amid Pending Acquisition

JTC PLC 2025 results: double‑digit growth while gearing up for a takeover

JTC has delivered a strong set of 2025 full‑year numbers, with robust organic momentum, healthy margins and record new business. All of this lands while the proposed £13.40 per share cash acquisition by Permira’s Papilio Bidco advances through approvals, with completion expected in Q3 2026.

Headline numbers investors should know

Metric	2025	2024	Change
Revenue	£381.9m	£305.4m	+25.1%
Underlying EBITDA	£124.5m	£101.7m	+22.4%
Underlying EBITDA margin	32.6%	33.3%	-0.7pp
Underlying profit for the year	£76.5m	£68.3m	+12.1%
Underlying EPS	45.55p	41.80p	+9.0%
Reported profit for the year	£0.9m	£(7.3)m	n/m
Cash conversion (underlying)	87%	98%	-11pp
Underlying net debt	£275.8m	£182.3m	+£93.4m
Leverage (underlying net debt/EBITDA)	2.22x	1.79x	+0.43x
Total dividend per share	5.00p	12.54p	-60.1%
New business wins (annualised)	£43.5m	£35.7m	+21.8%

Quick jargon check: “Underlying” strips out non‑recurring or acquisition‑related items to show the core performance. “Net organic growth” is growth from existing and new non‑acquired clients, at constant currency.

Why reported profit looks muted despite strong trading

You’ll notice the big gap between underlying EPS of 45.55p and basic EPS of 0.56p. That’s down to £75.6m of non‑underlying items, notably £16.8m of Employee Incentive Plan (EIP) charges, £26.7m of acquisition and integration costs, and higher amortisation of acquired intangibles. None of this is surprising for an active consolidator like JTC and for a year that included the transformational Citi Trust deal.

Two further points to keep in mind: interest costs rose as the group drew £184.2m of new debt and issued $75m of US private placement notes at 6.25%, which partly explains why underlying EPS grew slower than EBITDA. Cash conversion dropped to 87% due to annual fees billed and collected by acquired businesses before completion; excluding Citi and KHT, conversion would have been 93%.

Divisional performance: ICS held its nerve; PCS powered ahead

Institutional Capital Services (ICS)

• Revenue £211.1m, up 16.7%.
• Net organic growth 9.0% despite slower fund launches and longer sales cycles.
• Underlying EBITDA £60.8m with a 28.8% margin (30.6% in 2024).

The US remained the standout region, with SALI and the broader US fund admin platform performing well. Margins softened as JTC invested for growth and should benefit as delayed mandates go live.

Private Capital Services (PCS)

• Revenue £170.8m, up 37.2%.
• Net organic growth 7.9% as teams focused on integrating Citi Trust and KHT.
• Underlying EBITDA £63.7m, margin steady at 37.3%.

This division has been the growth engine, cementing JTC’s position as the largest independent, non‑bank trust company in the US after acquiring Citi’s global fiduciary and trust administration business. New business wins rose 20.4% to £18.3m, with strong traction in the US and Caribbean.

Geography: US and Caribbean doing the heavy lifting

Revenue growth by region highlights where the momentum is:

• US up 28.0% to £123.5m and now 32.3% of group revenue.
• Caribbean up 118.8% to £57.5m, boosted by Citi Trust.
• UK & Channel Islands up 9.5% to £148.7m; Rest of Europe up 6.5% to £43.4m; Rest of the World up 46.4% to £8.8m.

Revenue retention remains exceptional at 98.6%, with client attrition of just 4.1%. That’s a key quality marker for a services business.

Balance sheet, liquidity and debt

Underlying net debt rose to £275.8m as JTC leaned into M&A. Leverage ended at 2.22x underlying EBITDA, above the 1.5x-2.0x guidance but, per management, would be within range on a full‑year contribution from acquisitions.

• Undrawn headroom: £27.4m on the £400m bank facility and £74.2m ($100m) on the US private placement shelf.
• Return on invested capital improved to 13.2% (2024: 12.6%), comfortably above the cost of capital.

In plain English: the balance sheet is doing what it should in a roll‑up year – funding deals that are already feeding into earnings and ROIC.

Strategy and M&A: from “Cosmos” to “Genesis”

JTC runs the business through multi‑year “eras”. Cosmos (launched 2024) aimed to double the group by 2027. Management now view that plan as materially complete and are moving into a new era, “Genesis”, aligned with prospective private ownership under Permira. The bank carve‑out theme remains a sweet spot; since 2010, JTC has completed ten such transactions.

Two 2025 deals stand out: the strategic acquisition of Citi Trust and the purchase of Kleinwort Hambros Trust Company (KHT). Both are integrating well and already trading at JTC margins, which bodes well for 2026.

Permira offer: what it means for shareholders

Papilio Bidco has agreed to acquire JTC at £13.40 per share, implying an enterprise value of around £2.7bn. Shareholders approved the transaction in January 2026. The remaining steps are regulatory consents and Court approval in Jersey; completion is expected during Q3 2026, subject to conditions.

Due to the proposed acquisition, there is no final dividend for 2025. Total dividends paid for the year were 5.00p per share.

My take: quality growth, minor margin pressure, clear catalysts

What looks positive

• Top‑line resilience: revenue +25.1% with 8.5% net organic growth and a record £43.5m of new wins.
• Margins holding up: 32.6% underlying EBITDA margin despite regulatory drag and integration work.
• US and Caribbean momentum alongside 98.6% revenue retention – a powerful combination.
• ROIC at 13.2% and improving, validating the acquisition strategy.

What to keep an eye on

• Leverage at 2.22x after a busy M&A year – expected to ease on full‑year contributions, but still worth monitoring.
• Regulatory workload and delayed fund launches have clipped chargeable time in ICS and trimmed margin by 0.7pp.
• Interest costs stepped up with new borrowings and the 6.25% USPP notes, which dampened EPS progression versus EBITDA.

Net‑net, the engine is running smoothly: organic growth, disciplined M&A, and sticky clients. With the Permira deal advancing and integrations on track, JTC enters its “Genesis” era with a strengthened platform and a deep pipeline.

Key takeaways for retail investors

• Operationally strong year: revenue £381.9m, underlying EBITDA £124.5m, underlying EPS 45.55p.
• Record new wins and best‑in‑class retention support future revenue visibility.
• PCS is thriving post‑Citi Trust; ICS is investing through a tougher backdrop but winning mandates.
• Acquisition by Permira at £13.40 per share is progressing, with completion targeted for Q3 2026.

Overall sentiment: positive. There are headwinds to margins and higher finance costs, but the growth drivers are intact and the pipeline healthy. If you follow listed administrators, this is a high‑quality print from JTC at a pivotal moment in its corporate journey.